| 531.42 6.23 (1.19%) | 04-19 16:00 | |||||||||||||
|
|
| Short term |  |
|||
| Mid term |  |
|||
| Targets | 6-month : | 629.68 | 1-year : | 735.46 |
| Resists | First : | 539.1 | Second : | 629.68 |
| Pivot price | 508.76 |
|||
| Supports | First : | 511 | Second : | 493.64 |
| MAs | MA(5) : | 514.52 |
MA(20) : | 510.56 |
| MA(100) : | 493.41 |
MA(250) : | 470.31 |
|
| MACD | MACD : | 2.6 |
Signal : | 0.7 |
| %K %D | K(14,3) : | 69.3 |
D(3) : | 56.5 |
| RSI | RSI(14): 65.3 |
|||
| 52-week | High : | 539.1 | Low : | 412 |
Price has closed above its short-term moving average. Short-term moving average is currently above mid-term; and above long-term moving average. From the relationship between price and moving averages: This stock is BULLISH in short-term; and BULLISH in mid-long term.[ ELV ] has closed Bollinger Bands are 40.4% wider than normal. The large width of the bands suggest high volatility as compared to its normal range. The bands have been in this wide range for 0 days. This is a sign that the current trend might continue.
| If tomorrow: | Open lower | Open higher |
| High: | 536.34 - 537.93 | 537.93 - 539.7 |
| Low: | 521.05 - 523 | 523 - 525.18 |
| Close: | 527.98 - 530.92 | 530.92 - 534.22 |
Elevance Health Inc. operates as a health benefits company. It supports consumers, families, and communities across the entire care journey connecting to the care, support, and resources to lead healthier lives. It serves approximately 118 million people through a portfolio of medical, digital, pharmacy, behavioral, clinical, and care solutions. The company was formerly known as Anthem, Inc. and changed its name to Elevance Health Inc. in June 2022. Elevance Health Inc. was founded in 1944 and is headquartered in Indianapolis, Indiana.
Fri, 19 Apr 2024
Elevance Health, Inc. (NYSE:ELV) Plans Quarterly Dividend of $1.63 - MarketBeat
Fri, 19 Apr 2024
Elevance Health, Inc. (NYSE:ELV) Stock Holdings Raised by Cornerstone Investment Partners LLC - MarketBeat
Fri, 19 Apr 2024
Elevance Health Analysts Boost Their Forecasts After Upbeat Earnings - Elevance Health (NYSE:ELV) - Benzinga
Fri, 19 Apr 2024
Elevance Health Inc (ELV) Q1 2024 Earnings Call Transcript Highlights: Robust Growth and Strategic Expansions - GuruFocus.com
Fri, 19 Apr 2024
Decoding Elevance Health Inc (ELV): A Strategic SWOT Insight - Yahoo Finance
Thu, 18 Apr 2024
Elevance Health (ELV) Q1 2024 Earnings Call Transcript - The Globe and Mail
| Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
Underperform |
| Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
Outperform |
| Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
Outperform |
| Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
Outperform |
| Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
Outperform |
| Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
Outperform |
|
Exchange:
NYSE
|
|
|
Sector:
Healthcare
|
|
|
Industry:
Medical - Healthcare Plans
|
|
| Shares Out | 233 (M) |
| Shares Float | 232 (M) |
| Held by Insiders | 0.2 (%) |
| Held by Institutions | 92.1 (%) |
| Shares Short | 2,090 (K) |
| Shares Short P.Month | 1,710 (K) |
| EPS | 25.21 |
| EPS Est Next Qtrly | 0 |
| EPS Est This Year | 0 |
| EPS Est Next Year | 0 |
| Book Value (p.s.) | 168.63 |
| Profit Margin | 3.4 % |
| Operating Margin | 5.6 % |
| Return on Assets (ttm) | 5.8 % |
| Return on Equity (ttm) | 15.8 % |
| Qtrly Rev. Growth | 6.8 % |
| Gross Profit (p.s.) | 0 |
| Sales Per Share | 736.59 |
| EBITDA (p.s.) | 47.07 |
| Qtrly Earnings Growth | 1.2 % |
| Operating Cash Flow | 8,060 (M) |
| Levered Free Cash Flow | 3,000 (M) |
| PE Ratio | 21.07 |
| PEG Ratio | 1.1 |
| Price to Book value | 3.15 |
| Price to Sales | 0.72 |
| Price to Cash Flow | 15.33 |
| Dividend | 0 |
| Forward Dividend | 0 |
| Dividend Yield | 0% |
| Dividend Pay Date | Invalid DateTime. |
| Ex-Dividend Date | Invalid DateTime. |
|
|
|
|
|
|
|
|
|